MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.

NCT ID: NCT00430352

Last Updated: 2017-08-14

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

545 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-09-04

Study Completion Date

2011-05-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This single arm study will evaluate the safety and efficacy of MabThera maintenance therapy following a MabThera-containing induction regimen in first line or relapsed patients with follicular non-Hodgkin's lymphoma. All patients will receive MabThera 375mg/m2 body surface area, as an intravenous infusion, every 8 weeks. The anticipated time on study treatment is 1-2 years, and the target sample size is 500+ individuals.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-Hodgkin's Lymphoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Group Type EXPERIMENTAL

rituximab [MabThera/Rituxan]

Intervention Type DRUG

375mg/m2 iv every 8 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

rituximab [MabThera/Rituxan]

375mg/m2 iv every 8 weeks

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients, \>=18 years of age;
* histologically confirmed grade 1, 2 or 3a follicular non-Hodgkin's lymphoma;
* patients who have received adequate (\>=8 cycles) induction therapy with MabThera as first line treatment, or treatment for relapsed disease;
* demonstrated partial or complete response to induction therapy.

Exclusion Criteria

* stable or progressive disease after most recent induction therapy;
* transformation to high grade lymphoma;
* patients with prior or concomitant malignancies, except non-melanoma skin cancer or adequately treated in situ cancer of the cervix.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoffmann-La Roche

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trials

Role: STUDY_DIRECTOR

Hoffmann-La Roche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University "Mother Theresa" Hospital Center; Oncology Department

Tirana, , Albania

Site Status

Instituo Lavalle de Oncologia; Hematology

Bahía Blanca, , Argentina

Site Status

Academia Nacional de Medicina; Inst. de Cardiologia

Buenos Aires, , Argentina

Site Status

Fundaleu; Haematology

Buenos Aires, , Argentina

Site Status

Hospital Churruca Visca; Haematology

Buenos Aires, , Argentina

Site Status

Hospital Jr Vidal; Jefe de Servicio de Clinica Medica/Hematologia

Corrientes, , Argentina

Site Status

Sanatorio Allende; Haematology

Córdoba, , Argentina

Site Status

HOSPITAL PRIVADO - CENTRO MEDICO DE CÓRDOBA; Dpto Oncología

Córdoba, , Argentina

Site Status

Hospital General San Martin; Haematology

La Plata, , Argentina

Site Status

Liverpool Hospital; Haematology

Liverpool, New South Wales, Australia

Site Status

Wollongong Hospital; Cancer Services

Wollongong, New South Wales, Australia

Site Status

Royal Brisbane Hospital; Oncology Department

Brisbane, Queensland, Australia

Site Status

Haematology & Oncology Clinics of Australia, Mater Medical Centre

South Brisbane, Queensland, Australia

Site Status

Mount Medical Center

Perth, Western Australia, Australia

Site Status

University Clinical Center of the Republic of Srpska, Clinic for Internal Disease, Hematology Dept

Banja Luka, , Bosnia and Herzegovina

Site Status

Inst. of Hematology

Kasindo, , Bosnia and Herzegovina

Site Status

Uni Hospital Mostar

Mostar, , Bosnia and Herzegovina

Site Status

Clinic of Oncology, University Clinical Center Sarajevo

Sarajevo, , Bosnia and Herzegovina

Site Status

CEHON

Salvador, Estado de Bahia, Brazil

Site Status

Nucleo de Oncologia da Bahia - NOB

Salvador, Bahia, Estado de Bahia, Brazil

Site Status

ONCOMED

Belo Horizonte, Minas Gerais, Brazil

Site Status

Centro de Tratamento Oncologico - Oncoclinica

Rio de Janeiro, Rio de Janeiro, Brazil

Site Status

Hospital das Clinicas - UFRGS; Medicina Interna

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Hospital Mae de Deus

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Hospital Sao Lucas - PUCRS

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Centro de Pesquisas Oncologicas - CEPON

Florianópolis, Santa Catarina, Brazil

Site Status

Hospital das Clinicas - UNICAMP; Hemoterapia

Campinas, São Paulo, Brazil

Site Status

Clinica Oncologica De Piracicaba Sc

Piracicaba, São Paulo, Brazil

Site Status

Hospital Alemao Oswaldo Cruz; Oncologia

São Paulo, São Paulo, Brazil

Site Status

Hospital Estadual do Servidor Publico; Hematologia

São Paulo, São Paulo, Brazil

Site Status

Hospital das Clinicas - FMUSP, Oncologia

São Paulo, São Paulo, Brazil

Site Status

UMHAT Dr Georgi Stranski; Hematology

Pleven, , Bulgaria

Site Status

Umhat S. George; Hematology

Plovdiv, , Bulgaria

Site Status

UMHAT Alexandrovska EAD; Hematology

Sofia, , Bulgaria

Site Status

National Center of Hematology & Transfusiology; Clinical Unit, Clinic of Hematology

Sofia, , Bulgaria

Site Status

Mhat Sveta Marina; Dept. of Haematology

Varna, , Bulgaria

Site Status

Centro Médico Carlos Ardila Lule

Bucaramanga, , Colombia

Site Status

Hospital Pablo Tobon Uribe

Medellin-Antioquia, , Colombia

Site Status

Clinical Hospital Centre Split; Dept Of Hematology

Split, , Croatia

Site Status

Clinical Hospital Centre Dubrava; Hematology Department

Zagreb, , Croatia

Site Status

University Hospital Center Zagreb; Haematology Department

Zagreb, , Croatia

Site Status

Hospital José Carrasco; Oncology Service

Cuenca, , Ecuador

Site Status

Hospital Carlos Andrade Marin; Servicio de Oncología

Quito, , Ecuador

Site Status

Oncology & Radiotherapy Centre; Oncology

Cairo, , Egypt

Site Status

Kanta-Hämeen Keskussairaala; Dept of Internal Medicine, Hematology

Hämeenlinna, , Finland

Site Status

Kymenlaakson keskussairaala

Kotka, , Finland

Site Status

Päijät-Hämeen Keskussairaala; Dept of Internal Medicine, Hematology

Lahti, , Finland

Site Status

Satakunnan Keskussairaala; Sisaetauti Osasto

Pori, , Finland

Site Status

Internist; Praxis Für Haemotologie & Onkologie

Bad Soden, , Germany

Site Status

Dres.Christian Sperling und Claudia Schelenz

Berlin, , Germany

Site Status

Onkologische Schwerpunktpraxis Kurfürstendamm

Berlin, , Germany

Site Status

Universitätsklinikum Bonn; Medizinische Klinik und Poliklinik I; Allgemeine Innere Medizin

Bonn, , Germany

Site Status

Dres. Matthias Adler Oliver Marschal und Andreas Pies

Braunschweig, , Germany

Site Status

Gemeinschaftspraxis

Duisburg, , Germany

Site Status

Internistische Praxis Dr. Plingen

Düsseldorf, , Germany

Site Status

Internistische Schwerpunktpraxis Erlangen

Erlangen, , Germany

Site Status

Praxis für Interdisziplinäre Onkologie und Hämatologie GbR

Freiburg im Breisgau, , Germany

Site Status

Onkologische Gemeinschaftspraxis, Prof. Dr. Gropp, Dr. Depenbusch und Dr. Rösel

Gütersloh, , Germany

Site Status

Überörtliche Gemeinschaftspraxis Schwerpunkt Hämatologie, internistische Onkologie & Palliativmed.

Hamburg, , Germany

Site Status

Onkologische Schwerpunktpraxis; Herrn Dr. Med. Bertram

Hamburg, , Germany

Site Status

Dres.Andreas Karcher und Stefan Fuxius

Heidelberg, , Germany

Site Status

Uniklinik Heidelberg, Medizinische Klinik & Poliklinik V

Heidelberg, , Germany

Site Status

Onkologische Schwerpunktpraxis (Eps-Gmbh)

Jena, , Germany

Site Status

Märkische Kliniken GmbH, Klinikum Lüdenscheid; Hämatologie / Onkologie

Lüdenscheid, , Germany

Site Status

Stauferklinikum Schwäb.Gmünd

Mutlangen, , Germany

Site Status

Gemeinschaftspraxis Dres. Schröder, Sieg

Mülheim, , Germany

Site Status

Onko. Gemeinschaftspraxis Dres. Tigges/ Böning/ Abenhardt/ Bosse

München, , Germany

Site Status

Dres.Ulrich Hutzschenreuter und Uwe Sauer

Nordhorn, , Germany

Site Status

Onkologische Praxis Oldenburg; Dres. Otremba, Reschke, Zirpel, Kühn und Ruff

Oldenburg, , Germany

Site Status

Praxis für Onkologie und Hämatologie

Recklinghausen, , Germany

Site Status

Diakonie-Klinikum Klinik für Innere Medizin III Abt.Hämatologie, intern. Onkologie und Palliativmedi

Schwäbisch Hall, , Germany

Site Status

Internistische Gemeinschaftspraxis Dres. Hoering/Von Ehr/Responde

Stuttgart, , Germany

Site Status

Haematologisch-Onkologische Praxis; Dr. med. Christoph Maintz und Matthias Groschek

Würselen, , Germany

Site Status

Laiko General Hospital - Uni of Athens; 1St Dept. of Internal Medicine

Athens, , Greece

Site Status

Attiko Hospital; Haematology Clinic

Athens, , Greece

Site Status

Theagenio Anticancer Hospital; Dept. of Haematology

Thessaloniki, , Greece

Site Status

Rambam Medical Center; Heamatology & Bone Marrow Transplantation

Haifa, , Israel

Site Status

Wolfson Mc; Haematology

Holon, , Israel

Site Status

Hadassah Ein Karem Hospital; Haematology

Jerusalem, , Israel

Site Status

Chaim Sheba Medical Center; Hematology BMT & CBB

Ramat Gan, , Israel

Site Status

Ichilov Sourasky Medical Center; Heamatology

Tel Aviv, , Israel

Site Status

Ospedale Civile Dello Spirito Santo; Divisione Di Ematologia

Pescara, Abruzzo, Italy

Site Status

Uni Degli Studi Di Bari, Policlinico; Cattedra Di Ematologia,Dipart. Di Medicina Interna E Publica

Bari, Apulia, Italy

Site Status

Ospedale Vito Fazzi; Div. Oncoematologia

Lecce, Apulia, Italy

Site Status

Az. Osp. C. Panico; Rep. Ematologia E Trapianto

Tricase - Le, Apulia, Italy

Site Status

Az. Osp. Pugliese; Dh Oncologico

Catanzaro, Calabria, Italy

Site Status

Ospedale S. Gennaro; Divisione Di Ematologia

Napoli, Campania, Italy

Site Status

Ospedale Cardarelli; Divisione Di Ematologia

Napoli, Campania, Italy

Site Status

A.O. Universitaria Policlinico S.Orsola-Malpighi Di Bologna

Bologna, Emilia-Romagna, Italy

Site Status

Arcispedale S. Anna; Sezione Di Ematologia

Ferrara, Emilia-Romagna, Italy

Site Status

A.O. Universitaria Policlinico Di Modena; Ematologia

Modena, Emilia-Romagna, Italy

Site Status

A.O.U. Policlinico di Modena-Dipartimento di Medicina Diagnostica, Clinica e di Sanità pubblica

Modena, Emilia-Romagna, Italy

Site Status

Irccs Centro Di Riferimento Oncologico (CRO); Dipartimento Di Oncologia Medica

Aviano, Friuli Venezia Giulia, Italy

Site Status

Az. Osp. Uni Ria Policlinico Tor Vergata; Unita Di Ematologia

Rome, Lazio, Italy

Site Status

Ospedale S. Eugenio; Divisione Di Ematologia

Rome, Lazio, Italy

Site Status

Univ. Cattolica La Sapienza; Cattedra Di Ematologia

Rome, Lazio, Italy

Site Status

Uni Cattolica; Divisione Di Ematologia

Rome, Lazio, Italy

Site Status

A.O. Universitaria S. Martino Di Genova; Ematologia 1

Genoa, Liguria, Italy

Site Status

A.O. Spedali Civili Di Brescia-P.O. Spedali Civili;U.O. Ematologia

Brescia, Lombardy, Italy

Site Status

Istituto S. Raffaele Monte Tabor; Divisione Ematologia E Utmo

Milan, Lombardy, Italy

Site Status

Ist. Nazionale Per Lo Studio E Cura Dei Tumori; Div. Ematologia Trapianto Midollo Osseo Allogenico

Milan, Lombardy, Italy

Site Status

Asst Grande Ospedale Metropolitano Niguarda; Dipartimento Di Ematologia Ed Oncologia

Milan, Lombardy, Italy

Site Status

ASST DI MONZA; Ematologia

Monza, Lombardy, Italy

Site Status

Irccs Policlinico San Matteo; Divisione Di Ematologia

Pavia, Lombardy, Italy

Site Status

Fondazione Del Piemonte Per L'oncologia Ircc Di Candiolo; Dipartimento Oncologico

Candiolo, Piedmont, Italy

Site Status

Az. Osp. S. Croce Ospedale Generale; Sezione Di Ematologia

Cuneo, Piedmont, Italy

Site Status

Univ. Piemonte Est Amedeo Avogadro; Div.Ematologia- Dip.Clinica Med.Sperim.& Ircad

Novara, Piedmont, Italy

Site Status

A.O. Universitaria S. Giovanni Battista-Molinette Di Torino; Ematologia 1

Turin, Piedmont, Italy

Site Status

A.O.U. Citta' Della Salute E Della Scienza-P.O. Molinette;S.C. Ematologia

Turin, Piedmont, Italy

Site Status

Ospedale Oncologico A Businco-Cagliari; Ematologia Sez.

Cagliari, Sardinia, Italy

Site Status

Ospedale V. Cervello; U.O. Ematologia E Trapianti

Palermo, Sicily, Italy

Site Status

Ospedale Ferrarotto; Divisione Di Ematologia

Via S. Sofia 78, Sicily, Italy

Site Status

Ospedale Civile; S.C. Ematologia

Pesaro, The Marches, Italy

Site Status

A.O. Univ.Ospedali Riuniti Umerto I -G.M.Lancisi G.Salesi; U.O. Clinica Di Ematologia

Torrette Di Ancona, The Marches, Italy

Site Status

Az. Osp. Di Careggi; Divisione Di Ematologia

Florence, Tuscany, Italy

Site Status

Ospedale Santa Chiara; Unita Operativa Di Ematologia

Pisa, Tuscany, Italy

Site Status

A.O. Universitaria Senese; Ematologia

Siena, Tuscany, Italy

Site Status

Azienda Ospedaliera S. Maria della Misericordia; Ematologia

Perugia, Umbria, Italy

Site Status

Uni Degli Studi; Dip.Med.Clinica E Sperim. Ematologia

Padua, Veneto, Italy

Site Status

Ospedale Di Vicenza; Nefrologia, Ematologia

Vicenza, Veneto, Italy

Site Status

Issste; Haematology

Chihuahua City, , Mexico

Site Status

Hospital Cima (Centro Internacional de Medicina) ; Haematology

Chihuahua City, , Mexico

Site Status

Hospital Central de Pemex Norte Azcapotzalco

Mexico City, , Mexico

Site Status

Hospital Español de Mexico

Mexico City, , Mexico

Site Status

Hospital Regional Issste; Oncologia

Monterrey, , Mexico

Site Status

Clinca San Jose; Haematology

Obregón, , Mexico

Site Status

Issstep Puebla, ; Haematology

Puebla City, , Mexico

Site Status

Spitalul Clinic Judetean de Urgenta Brasov,Clinica de Hematologie

Brasov, , Romania

Site Status

Fundeni Clinical Inst. ; Hematology Dept

Bucharest, , Romania

Site Status

Spitalul Clinic Coltea; Clinica de Hematologie

Bucharest, , Romania

Site Status

Oncology Inst. Cluj-Napoca; Cancer Dept

Cluj-Napoca, , Romania

Site Status

Spitalul Clinic Judetean de Urgenta Sf. Spiridon Iasi, Clinica de Hematologie

Iași, , Romania

Site Status

Spitalul Clinic Judetean de Urgenta Targu-Mures; compartiment Hematologie

Târgu Mureş, , Romania

Site Status

Regional Clinical Hospital; Hematology

Belgorod, , Russia

Site Status

Clinical Oncology Dispensary of Ministry of Health of Tatarstan

Kazan', , Russia

Site Status

Blokhin Cancer Research Center; Clinical Oncology

Moscow, , Russia

Site Status

City Clinical Hospital After Botkin; Hematology

Moscow, , Russia

Site Status

Vladimirskiy Regional Scientific Research Inst. ; Hematology

Moscow, , Russia

Site Status

Regional Clinical Hospital N.A. Semashko; Hematology

Nizhny Novgorod, , Russia

Site Status

City Hematological Center of Clinical Hospital #2; Hematology

Novosibirsk, , Russia

Site Status

Rostov State Medical Uni ; Hematology

Rostov-on-Don, , Russia

Site Status

Research Inst. of Hematology & Blood Transfusion ; Hematology

Saint Petersburg, , Russia

Site Status

Pavlov State Medical Uni ; Bone Marrow Transplantation Clinic

Saint Petersburg, , Russia

Site Status

Leningrad Regional Clinical Hospital; Hematology #1

Saint Petersburg, , Russia

Site Status

Stavropol Clinical Oncology Dispansary

Stavropol, , Russia

Site Status

Bashkirian Republican Clinical Oncology Dispensary

Ufa, , Russia

Site Status

Ulyanovsk Regional Oncology Dispensary; Chemotherapy

Ulyanovsk, , Russia

Site Status

Regional Oncology Center; Chemotherapy

Volgograd, , Russia

Site Status

Regional Clinical Hospital; Hematology

Yaroslavl, , Russia

Site Status

Fakultna Nemocnica Roosevelta; Dept. of Haematology

Banská Bystrica, , Slovakia

Site Status

National Oncology Inst. ; Dept. of Haematology

Bratislava, , Slovakia

Site Status

Uni Hospital; Clinic of Haematology

Košice, , Slovakia

Site Status

Uni Hospital ; Dept. of Haematol. & Transfusion Medicine

Martin, , Slovakia

Site Status

Institute of Oncology Ljubljana

Ljubljana, , Slovenia

Site Status

Hospital General de Castellon; Servicio de Hematologia

Castellon, Castellon, Spain

Site Status

Complejo Asistencial Universitario De Burgos; Servicio de Oncologia

Burgos, , Spain

Site Status

Hospital Generla de Ciudad Real; Servicio de Oncologia

Ciudad Real, , Spain

Site Status

Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia

Jaén, , Spain

Site Status

Hospital El Bierzo; Servicio de Oncologia

León, , Spain

Site Status

Hospital Costa del Sol; Servicio de Hematologia

Málaga, , Spain

Site Status

Hospital Universitario Virgen de Arrixaca; Servicio de Oncologia

Murcia, , Spain

Site Status

Hospital Universitario Virgen Macarena; Servicio de Hematologia

Seville, , Spain

Site Status

Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia

Valencia, , Spain

Site Status

Laenssjukhuset; Medicinkliniken/Hematologsektionen

Halmstad, , Sweden

Site Status

Sunderby Sjukhus; Medicinkliniken

Luleå, , Sweden

Site Status

Skånes Universitetssjukhus; Kliniska Forskningsenheten Onkologimottagning medicinsk behandling

Malmo, , Sweden

Site Status

Länssjukhuset Sundsvall-Härnösand, Medicinkliniken

Sundsvall, , Sweden

Site Status

Uddevalla Sjukhus; Medicinkliniken

Uddevalla, , Sweden

Site Status

Akademiska sjukhuset, Onkologkliniken

Uppsala, , Sweden

Site Status

Andreas Klinik; Onko-Hämatologisches Zentrum Cham Zug

Cham, , Switzerland

Site Status

Kantonsspital Graubünden;Onkologie und Hämatologie

Chur, , Switzerland

Site Status

Clinica Santa Chiara; Oncologia / Ematologia

Locarno, , Switzerland

Site Status

UniversitätsSpital Zürich; Zentrum für Hämatologie und Onkologie, Klinik für Onkologie

Zurich, , Switzerland

Site Status

Ankara Numune Egitim Ve Arastirma Hastanesi; Hematoloji Klinigi

Ankara, , Turkey (Türkiye)

Site Status

Hacettepe Uni Medical Faculty; Hematology

Ankara, , Turkey (Türkiye)

Site Status

Gazi Uni Medical School; Hematology

Ankara, , Turkey (Türkiye)

Site Status

Istanbul Uni Capa Hospital; Hematology

Istanbul, , Turkey (Türkiye)

Site Status

Ege Uni Medical School; Hematology

Izmir, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Albania Argentina Australia Bosnia and Herzegovina Brazil Bulgaria Colombia Croatia Ecuador Egypt Finland Germany Greece Israel Italy Mexico Romania Russia Slovakia Slovenia Spain Sweden Switzerland Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Witzens-Harig M, Foa R, Di Rocco A, van Hazel G, Chamone DF, Rowe JM, Arcaini L, Poddubnaya I, Ho AD, Ivanova V, Vranovsky A, Thurley D, Oertel S. Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study. Ann Hematol. 2014 Oct;93(10):1717-24. doi: 10.1007/s00277-014-2103-3. Epub 2014 May 14.

Reference Type DERIVED
PMID: 24824768 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MO19872

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.